NATNICHA KANLOP, M.D.

Medical Consultant, Anti-Aging Center

Professional Experience

2018

Medical Consultant, Anti-Aging & Rejuvenation Center, Novavida Integrative Medical Center, Thailand

2015

Medical Consultant, Holistic Medical Center, Thailand

2014

Medical Consultant, Wellness Center, NakornthonHosopital, Thailand

2011

General Physician, Ladprao Hospital, Thailand

2007 – 2010

Intructor, Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai , Thailand

2007 – 2010

Staff, Cardiac Electrophysiology Research and Training Center,Department of Physiology, Faculty of Medicine,   Chiang Mai University, Chaing Mai, Thailand

2006 – 2007

Internship, Cardiac Electrophysiology Research and Training Center, Deepartment of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

Education

2015

American Board of Anti-Aging, The American Academy of Anti-Aging Medicine, USA

2016

Clinical Practice in Applying Functional Medicine, The Institute of Functional Medicine, USA

2007

Internship, Department of Physiology, Faculty of Medicine Chiang Mai University, Thailand

2005

Doctor of Medicine (M.D.), Srinakharinwirot University, Bangkok, Thailand

Organization and Participation

2017

American Academy of Anti-Aging Medicine, USA

2012

Association of Cell Therapy, Thailand

2012

Chelation Medical Association, Thailand

2012

Thai Association of Anti-Aging and Regenerative Medicine (TAARM) 2005 Thai Medical Council

2008

The ACC Meeting, Orlando, USA

2008

The ESC Congress Meeting, Munich, Germany

2007

Heart Rhythm Association (EUROPACE)

2006

The Medical Association of Thailand

Honor and Award

2012

Best Research Award from Research Fund (TRF

2008

Research Fellowship Award of Takeda Science Foundation for Short Training in University of the Ryukyu.

Professional Activities

2008 – 2010

Editorial board Journal of physiological and Biomedical Science (JPBS)

Peer-Reviewed Articel

  • Chattipakom N, Incharoen T, Kanlop N, Chattipapakom S. Heart rate variablility in myocardial infarction and heart failure. Int J Cardiol 2007 (120); 289-296
  • Kanlop N, Sungnoon R, Chattipakom S, Chattipakon N. Effects of sildenafil citrate on the induciblility of ventricular arrhythmia and the upper limit of vulnerablility. Med Sci Monit 2008 Oct; 14 (10) : BR205-9.
  • Sungnoon R, Kanlop N, Chattipakom SC, Tawan R, Chattipakom N. Effects of garlic on the induction of ventricular fibrillation. Nutrition 2008 ; 24 (7-8) : 71 1-6.
  • Rutjanaprom W, Kanlop N, Charoenkwan P, Sittiwangkul R, Srichairatanakool S, Tantiworawit A, Phrommintikul A, Chattipakom S, Fucharoen S, Chattipakom N., Heart rate variability in Beta-Thalassemia patients. Eur J Haematol. 2009 Nov; 83(5) : 483-9. Epub 2009 Jul 6.
  • Kanlop N, Shinlapawittayatom K, Sungnoon R, Weerateerangkul P, Chattipakom S Chattipakom N., Cilostazol Attenuates Ventricular Arrhythmia Induction and Improves Defibrilation Efficacy in Pigs. Can J PhysiolPharmacol. 2010 Apr;88 (4):422-8. doi: 10 1139/) 209-127.
  • Kanlop N, Tetsuro S. Optical mapping study of blebbistatin-induced chaotic electrical activities in isolated rat atrium preparations. J Physiol Sci. 2010 Mar;60(2):109-17. doi: 10.1007/s12576-009-0074-2. Epub 2009 Dec 1 6.
  • Kanlop N, Rutjanaprom W, Weerateerangkul P, Chattipakom N., Effects of Granulocyte colony-stimulating factor on the ventricular fibrillation prevention and defibrillation efficacy in ischemic-reperfusion model in swine. Acta Physiol (Oxf).

Peer-Reviewed Abstracts

  • Effects of sildenafil citrate on the inducibility of ventricular arrhythmia. Kanlop N, Lailerd N, Chattipakom S, Chattipakom N. EUROPACE 2007; Supplement 3(9):iiil47.
  • Effects of a selective phosphodiesterase type III inhibitor on the defibrillation efficacy. ChattipakomN, Kanlop N, Shinlapawittayakom K, Chattipakom S. Eur Heart J 2007;28:29.
  • Novel effects of phosphodiesterase-3 inhibitor in prevention of initiation of ventricular fibrillation and stabilization of myocardial electrophysiology. Kanlop N, Rutjanaprom W, Weerateerangkul P, Chattipakom N. Eur Heart J 2008; Vol 29 (Abstract Suppl.)
  • Effects of Kaempferiaparviflora on defibrillation efficacy. Weerateerangkul P, Kanlop N, Rutjanapro W, Chattipakom N. Proceedings to the 37th Physiological Society of Thailand annual conferrence 2008;40.
  • Heart rate variability in Children with thalassemia major. Rutjanaprom W, Kanlop N, Charoenkwan P, Sittiwmngkuo R, Srichairattanakool S, Fucharoen S, Chttipakom N. Proceedings to the 37! Physiological Sodiety of Thailand annual conference 2008;44.
  • Stabilization of cardiac electrophysiology in ischemic myocardium by Granulocyte Colony Stimulating Factor. Kanlop N, Ratjanaprom W, Weerateerangkul P, Chattipakom N. J Am Coll Cardiol 2009 53.’ Issue 10 SupplA.